相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition
Yoshihiro Otani et al.
CLINICAL CANCER RESEARCH (2020)
Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA
Wei Wang et al.
MOLECULAR CANCER (2020)
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe et al.
FRONTIERS IN ONCOLOGY (2020)
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer
Da-Hyun Kim et al.
BMB REPORTS (2020)
A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy
Gizem Duru et al.
FRONTIERS IN IMMUNOLOGY (2020)
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
Antonio Jimeno et al.
INVESTIGATIONAL NEW DRUGS (2019)
Quantitative analysis on in vivo tumor-microvascular images from optical-resolution photoacoustic microscopy
Qian Zhao et al.
JOURNAL OF BIOPHOTONICS (2019)
The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models
Rihong Zhou et al.
EXPERIMENTAL CELL RESEARCH (2019)
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer
Francesca Negri et al.
ONCOLOGY REPORTS (2019)
Contribution of Tumor Endothelial Cells in Cancer Progression
Kyoko Hida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models
Yingchun Li et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer
Monika A. Jarzabek et al.
PLOS ONE (2018)
Notch Signaling in Myeloid Cells as a Regulator of Tumor immune Responses
Fokhrul Hossain et al.
FRONTIERS IN IMMUNOLOGY (2018)
An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization
Rasoul Baharlou et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
Notch and its oncogenic activity in human malignancies
Marlena Brzozowa-Zasada et al.
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo
Alexandre Trindade et al.
BMC CANCER (2017)
Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis
Dongheon Lee et al.
MABS (2016)
Notch signalling pathway as an oncogenic factor involved in cancer development
Marlena Brzozowa-Zasada et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
Endothelial Jagged1 Antagonizes Dll4 Regulation of Endothelial Branching and Promotes Vascular Maturation Downstream of Dll4/Notch1
Ana-Rita Pedrosa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy
Ya-Rong Liu et al.
BIOMATERIALS (2015)
Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas
Dusan Djokovic et al.
BMC CANCER (2015)
The complex interplay between Notch signaling and Snail1 transcription factor in the regulation of epithelial-mesenchymal transition (EMT)
M. Brzozowa-Zasada et al.
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA (2015)
Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas
Xian-xin Qiu et al.
JOURNAL OF NEUROSURGERY (2015)
Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice
Amrita V. Kamath et al.
MABS (2014)
High Delta-Like Ligand 4 (DLL4) Is Correlated With Peritumoral Brain Edema and Predicts Poor Prognosis in Primary Glioblastoma
Xian-xin Qiu et al.
MEDICINE (2014)
Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma
Wei Wang et al.
ONCOLOGY LETTERS (2014)
Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway
Jingru Zhang et al.
CARCINOGENESIS (2013)
Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4
Qing Bo Huang et al.
PLOS ONE (2013)
Role of Notch signaling pathway in gastric cancer pathogenesis
Marlena Brzozowa et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2013)
Fine-tuning of the intracellular canonical Notch signaling pathway
Tilman Borggrefe et al.
CELL CYCLE (2012)
Cross-talk between endothelial cells and tumor via delta-like ligand4/Notch/PTEN signaling inhibits lung cancer growth
Y. Ding et al.
ONCOGENE (2012)
Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations
Marcus Fischer et al.
CANCER RESEARCH (2011)
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
Ji-Liang Li et al.
CANCER RESEARCH (2011)
Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications
Katrien De Bock et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer
Francesco Bertolini et al.
DRUG DISCOVERY TODAY (2011)
Expression of Vascular Notch Ligand Delta-Like 4 and Inflammatory Markers in Breast Cancer
Adrian M. Jubb et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
G. Thurston et al.
BRITISH JOURNAL OF CANCER (2008)
Notch and cancer: a double-edged sword
U. Koch et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Anti-DII4 therapy: can we block tumour growth by increasing angiogenesis?
Richard C. A. Sainson et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer
Nilay S. Patel et al.
CLINICAL CANCER RESEARCH (2006)
Recent insights into the role of Notch signaling in tumorigenesis
KG Leong et al.
BLOOD (2006)
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function
NS Patel et al.
CANCER RESEARCH (2005)
Tumour angiogenesis: vascular growth and survival
A Giatromanolaki et al.
APMIS (2004)
分享论文
